CWM, LLC

Position in PRME — Prime Medicine, Inc.

CIK 1535847 OMAHA, NE

Position in PRME

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$117,662

+$29,431 QoQ

Shares Held

33,811

+33.0% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 4% Shared 0% None 96%

Healthcare · as of Mar 31, 2026

CWM, LLC holds $167,669,594 across 306 Biotechnology names. PRME ranks #80 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	66,400	$51,303,296
2	MRNA	Moderna, Inc.	386,906	$19,654,824
3	INCY	Incyte Corp	202,772	$19,084,900
4	EXEL	Exelixis, Inc.	263,476	$11,300,485
5	BMRN	Biomarin Pharmaceutical Inc	159,652	$9,018,741
6	ROIV	Roivant Sciences Ltd.	181,899	$5,038,602
7	SRPT	Sarepta Therapeutics, Inc.	198,333	$4,315,726
8	VRTX	Vertex Pharmaceuticals Inc / Ma	8,609	$3,844,262

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$117,662	33,811	+33.0%	Shares	Sole	2026-05-14
2025-12-31	$88,231	25,427	+0.3%	Shares	Sole	2026-01-26
2025-09-30	$140,450	25,352	-29.1%	Shares	Sole	2025-10-15
2025-06-30	$88,329	35,761	+74.7%	Shares	Sole	2025-07-25
2025-03-31	$40,727	20,466	+741.5%	Shares	Sole	2025-05-01
2024-12-31	$7,101	2,432	+10954.5%	Shares	Sole	2025-02-04
2024-09-30	$85	22	-93.3%	Shares	Sole	2024-10-08
2024-06-30	$2	326	+552.0%	Shares	Sole	2024-07-10
2024-03-31	$350	50	+8.7%	Shares	Sole	2024-04-05
2023-12-31	$407	46	+206.7%	Shares	Sole	2024-02-01
2023-06-30	$219	15	0.0%	Shares	Sole	2023-08-03
2023-03-31	$184	15	—	Shares	Sole	2023-05-01
No filing history on record for this holder in this stock.